Plus: A look at the foundation charging cancer patients $83,000 for unproven, experimental personalized vaccinesMarch 7, 2023Check out STAT+Sponsored By Adobe STAT+ | An mRNA vaccine for cancers associated with HPV shows promise in mice A new study of mRNA vaccines in mice points to a hopeful possibility for people with cancers associated with HPV infections. By Angus Chen What is basal cell carcinoma, the skin cancer Biden just had A slow-growing, common, easily curable cancer – but still a concern if left untreated. Experts suggest reaching for sunscreen. By Angus Chen and Rachel Cohrs STAT+ | Foundation charges cancer patients $83,000 for unproven but promising experimental drug Unlike most people who receive medications yet to be cleared by the FDA, these patients are not getting vaccines as part of a clinical trial. By Jonathan Saltzman — Boston Globe More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments